Cardiac surgery
Our cardiac surgery destination for education, evidence, and innovation. We update our information and features frequently. Check back for upcoming physician news and stories.
New cardiac surgery podcast — The Cardiac Exchange
Listen. Learn. Connect. And be inspired.
Medical education
Dr. Bolling reflects on mitral valve repair wet labs at his institution.
Assessing mitral regurgitation
Dr. Martin shares his considerations for assessing mitral regurgitation.
Education
Check our training programs, roundtable discussions, and education resources for the treatment of mitral and tricuspid diseases.
Webinars
Global Grand Rounds
Grand Rounds are interactive global webcasts delivered by industry-leading experts on a wide range of relevant topics. Listen to Drs. Bavaria and Klautz discuss Today's SAVR Patient: Case Based Discussions Valve Design and Impact on Clinical Outcomes.
Featured products
Crescent™* RA Jugular Dual Lumen Catheter
Rediscover pediatric VV ECMO.
You spoke. We listened.
Only physicians with previous training and experience with venous catheterization and extracorporeal life support should use this device.
Avalus™ Bioprosthesis
A design platform for long-term durability. Interior-mounted leaflets that leverage our proprietary AOA™ tissue treatment.
No clinical data is available which evaluates the long-term impact of AOA treatment in patients.
Evidence
Innovations
Mitral repair/tricuspid repair
A complete portfolio of rigid, semi-rigid, and flexible annuloplasty products designed specifically for a more physiological mitral and tricuspid valve repair.
Valve replacement
Aortic, mitral, bovine, and porcine tissue; stented, stentless, and mechanical — we have a full portfolio to meet your needs.
CABG-enabling technologies
Beating heart procedures and sicker coronary patients — we can help you find the right procedure for the right patient.
Cardiopulmonary and blood management
Innovative and proven, a complete portfolio to optimize your circuit and blood product utilization.
Cannulae
Unmatched selection of cannulae — pediatric and adult — to facilitate insertion and drainage techniques.
Extracorporeal life support
Your mission is our mission — providing you with products designed for ECMO.
Surgical ablation
Achieve transmural lesions with temperature-controlled ablation systems.
Minimally invasive cardiac surgery
A video library of MICS techniques and approaches.
Equipment services and support
Maximum equipment UPTIME. You expect it, patients rely on it, and we deliver it.
News and stories
Stay up to date with physician experiences, patient stories, and much more.
Connect with us
Follow us on social media
Stay up to date with new products, innovative stories, and events:
- Twitter: @MDT_Cardiac
- LinkedIn: Cardiac & Vascular
- YouTube: See videos
Sign up for updates
Get the latest cardiac surgery updates from Medtronic.
Helpful information
Contact information
CardioVascular LifeLine
877-526-7890
rs.structuralheart@medtronic.com
Education and training
View our education and training materials for more information.
™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Crescent™* RA jugular dual lumen catheter is manufactured by MC3, Inc. and exclusively distributed by Medtronic. Crescent™* RA jugular dual lumen catheters are not approved in every geography.
References
1
Tadokoro N, Fukushima S, Shimahara Y, et al. Comparison of safety and haemodynamic performance between the Avalus™ stented aortic valve bioprosthesis and Magna™ valve in Japanese patients. Gen Thorac Cardiovasc Surg. July 2021;69(7):1060-1069.
2
The latest results of the Perigon Study, presented by Prof. Dr. Robert J.M. Klautz during EACTS 2021: Surgical Aortic Valve Replacement with a Stented Pericardial Bioprosthesis: 5-year Outcomes. The PERIGON Pivotal Trial regarding the Avalus valve is a prospective, interventional, nonrandomized, worldwide, multi-site trial, with each center following a common protocol. The study was designed in accordance with the recommendations of the EN ISO 5840:2009 standard for cardiac valve prostheses and the U.S. Food and Drug Administration (FDA) Heart Valve Guidance (2010; DRAFT) and conducted in accordance with the Declaration of Helsinki and good clinical practice guidelines. Valve-related events and deaths were adjudicated by an independent clinical events committee (CEC). All study echocardiograms were analyzed by an independent core laboratory (MedStar Health Research Institute, Washington, D.C.). Safety oversight was provided by an independent data and safety monitoring board (DSMB). This trial is registered at www.clinicaltrials.gov, NCT02088554.